middle.news
ImpediMed Drives Record Q3 Revenue Amid Strategic Sales Overhaul
5:27am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
ImpediMed Drives Record Q3 Revenue Amid Strategic Sales Overhaul
5:27am on Monday 2nd of June, 2025 AEST
Key Points
Record quarterly revenue of A$3.4 million, up from A$3.3 million in Q2 FY25
Annual Recurring Revenue increased to A$13.7 million from A$12.5 million
Core Business Total Contracted Value rose to A$4.9 million, driven by renewals and 19% average price increases
Appointment of Scott Long as new SVP of Sales to spearhead growth
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Impedimed (ASX:IPD)
OPEN ARTICLE